Assessing Protein Immunogenicity with a Dendritic Cell Line-Derived Endolysosomal Degradome
Author Information
Author(s): Matthias Egger, Alexander Jürets, Michael Wallner, Peter Briza, Silke Ruzek, Stefan Hainzl, Ulrike Pichler, Claudia Kitzmüller, Barbara Bohle, Christian G. Huber, Fátima Ferreira
Primary Institution: University of Salzburg
Hypothesis
The study aims to establish an in vitro assay that links a protein's immunogenicity to its susceptibility to endolysosomal proteolysis.
Conclusion
Endolysosomal fractions from the JAWS II cell line can reliably estimate protein immunogenicity and may help reduce animal experiments in allergy research.
Supporting Evidence
- Antigens with weak T cell priming capacity were more susceptible to endolysosomal proteases.
- The JAWS II cell line can substitute for freshly isolated human or murine cells in degradation assays.
- Endolysosomal degradation kinetics varied significantly among different antigen variants.
Takeaway
Scientists created a lab test to see how well proteins can trigger immune responses without using animals, which is better for research and safety.
Methodology
The study compared protein composition and proteolytic activity of endolysosomal fractions from murine and human dendritic cells and evaluated antigen variants' in vitro degradation.
Limitations
The method cannot fully replicate the complex in vivo antigen processing and may not accurately reflect immunogenicity in all cases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website